Abreu’s group at USC provides an overview of the transperineal MRI/TRUS fusion prostate biopsy also utilizing the freehand technique.
The video above, as well as videos from Amir H. Lebastchi, MD, Luke O’Connor, PhD, and Peter A. Pinto, MD;and Arvin George, MD, illustrate techniques for performing transperineal prostate biopsy. Commentary on the videos is provided by Lebastchi, clinical fellow in urologic oncology, Urologic Oncology Branch, National Cancer Institute, Bethesda, MD.
Lebatschi: Abreu’s group at USC provides an overview of the transperineal MRI/TRUS fusion prostate biopsy also utilizing the freehand technique. While the Trinity system provides the capability to perform the transperineal biopsy utilizing a needle-guide and probe holder, the authors prefer performing the technique freehand. After advancing a coaxial needle toward the apex through the ipsilateral side of the perineum, a biopsy needle is inserted and a virtual biopsy is performed first. Once the virtual biopsy hits the target, a reference image is taken. Under TRUS guidance, a real-time image matches the reference image, and the biopsy gun is fired. Trajectories are tracked to confirm whether the targets are adequately sampled. Following the targeted biopsies, the USC team routinely performs a standard systematic biopsy.
Abreu is assistant professor, Institute of Urology, University of Southern California, Los Angeles.
'Y'tube Section Editor James M. Hotaling, MD, MS, is assistant professor of surgery (urology) at the Center for Reconstructive Urology and Men's Health, University of Utah, Salt Lake City.
Targeted radiation plus systemic therapy combo shows promise in mHSPC
March 18th 2024"The combination of highly potent systemic therapy and targeted radiation has shown impressive results in maintaining low PSA levels after testosterone recovery, offering hope for improved outcomes in these patients, but further studies are still needed to determine the best regimen," says Amar U. Kishan, MD.
Agents show potential to bolster precision medicine in prostate cancer
March 12th 2024"[Now that] we have entered the era of precision and personalized medicine, well-designed clinical trials are needed to address selected focused questions regarding optimal therapy sequencing,” says Maha H.A. Hussain, MBChB.